Moderna will start producing a retooled version of its coronavirus vaccine in the Netherlands, doubling the company’s expected EU production, the company announced today.
The new contract, inked with the subcontractor Lonza, will allow Moderna to make approximately 300 million doses a year starting at the end of 2021. The Dutch site, in addition to a drug-substance site run by Rovi in Spain, will allow Moderna to make 600 million doses a year in the EU.
Currently, the American company doesn’t make any drug substance in the EU. Instead, it has outsourced its vaccine substance production to Lonza’s site in Switzerland to supply the EU, U.K. and Canada. But
→ Continue reading at Politico